Functional effects of treatment of organ confined prostate cancer on lower urinary tract

Functional effects of treatment of organ confined prostate cancer on lower urinary tract - urodynamics in prostate cancer treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33683

Enrollment

120

Registered

2007-12-04

Start date

2008-11-05

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urinary urgency /urinary leak

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Proven organ confined prostate cancer with indication for curative treatment

Exclusion criteria

Exclusion criteria: (locally) advanced prostaat carcinoom

Design outcomes

Primary

Measure	Time frame
Urodynamic changes in comparison with the baseline: • Maximum flow rate • Volume of the first muscle instability. • Amplitude of the first instable contraction • Amplitude of the maximal instable contraction • Volume of the maximal instable contraction • Volume of the first desire to urinate • Bladder compliance before and after brachytherapie • Maximale urethral closure pressure (MUCP) • Urethrale pressure profile-length • Urethrale resistance/URA_BOOI • Schafer graad • Bladder contractility index:PQmax+5xQmax, Wmax, WQmax * Post-void residue * 24 uur padtest	—

Measure

Time frame

Urodynamic changes in comparison with the baseline: • Maximum flow rate • Volume of the first muscle instability. • Amplitude of the first instable contraction • Amplitude of the maximal instable contraction • Volume of the maximal instable contraction • Volume of the first desire to urinate • Bladder compliance before and after brachytherapie • Maximale urethral closure pressure (MUCP) • Urethrale pressure profile-length • Urethrale resistance/URA_BOOI • Schafer graad • Bladder contractility index:PQmax+5xQmax, Wmax, WQmax * Post-void residue * 24 uur padtest

—

Secondary

Measure	Time frame
The subjetive changes of parameters in comparison with the baseline: International Prostate Symptom Score (IPSS) • Frequentie- volume Chart • EPIC-MICTURATION • EPIC-INTESTINAL SYMPTOMS • EPIC-SEXUALITY	—

Countries

Netherlands

Outcome results